Please login to the form below

Not currently logged in
Email:
Password:

Golin appoints healthcare director

Shani Shaker to oversee the expansion of the London practice

Golin Shani ShakerGolin has appointed Shani Shaker as director of its London healthcare practice.

Shaker joins the public relations and digital-focused agency from Salt Communications, where she was an associate director for the Unilever brands portfolio.

Prior to this, Shaker served as a senior consultant for several communications agencies, including Kaizo, Fleishman-Hillard, Clarion Communications, Fox Communications, Grayling and Talk PR.

She also brings experience as an associate director from Porter Novelli and Edelman, where she led a number of consumer health and beauty campaigns.

As healthcare director at Golin, Shaker will be responsible for the growing its consumer health portfolio and the overall expansion of the team.

Siân Boisseau, executive director of health at Golin, said: “We have such ambitious plans and great momentum for health in 2017 so Shani's credentials and passion for consumer healthcare are the perfect match.

“Her arrival will take the creative bravery of our client work to another level. 2017 will be quite a year!”

31st January 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics